Preventing blood clots in cancer patients receiving outpatient care
Official title: Implementing Prevention of Venous Thromboembolism for Ambulatory Patients with Cancer (PREVenT-APC)
Funded at University of Vermont & St Agric College · NIH-11094449 · Data updated 2026-11-12
This study is looking at ways to help doctors better prevent blood clots in cancer patients who are not in the hospital, so they can stay safer and healthier during their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Vermont & St Agric College NIH-funded |
| Lab location | 1 site (Burlington, United States) |
| Project start | May 24, 2024 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $166,323 |
| NIH project number | 7K23HL157758-03 |
| Project ID | NIH-11094449 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are ambulatory cancer patients who are identified as being at high risk for venous thromboembolism.
✕Less likely to help
Patients who are not currently undergoing cancer treatment or those who are hospitalized may not benefit from this research.
What this research studies
This research focuses on improving the prevention of venous thromboembolism (VTE), a serious condition that can lead to death in cancer patients. It aims to develop and implement a strategy that encourages healthcare providers to assess the risk of VTE in ambulatory cancer patients and to provide appropriate preventive treatment. The study will involve creating a tailored implementation plan and testing its effectiveness compared to standard care. By understanding how to better integrate these guidelines into practice, the research seeks to enhance patient safety and outcomes.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of life-threatening blood clots in cancer patients receiving outpatient treatment.
How similar studies have gone: Previous research has shown that implementing structured prevention strategies can effectively reduce VTE rates in high-risk populations, suggesting that this approach has potential for success.
Where this research is happening
-
University of Vermont & St Agric College
Burlington, United States Active
Researchers
- Principal investigator: Martin, Karlyn — University of Vermont & St Agric College
- Study coordinator: Martin, Karlyn
Related research
Other NIH-funded projects on the same topics.
-
Statins to Prevent Cancer-Associated Blood Clots in Cancer Patients
A large study will test whether taking rosuvastatin every day for a year can lower the chance of dangerous blood clots in people with cancer, without raising the risk of bleeding.
-
Optimal use of blood thinners for venous clots in people with cirrhosis
This grant hopes to figure out the safest and most effective way to use oral anticoagulants for adults with cirrhosis who develop venous clots.
-
PET/CT imaging to detect chemotherapy-related vascular harm in young cancer patients
A non-invasive PET/CT scan method using standard care imaging is being tested to identify which pediatric and young adult cancer patients are at higher risk of blood clots from chemotherapy.
-
Statins to Prevent Cancer-Associated Blood Clots in Cancer Patients
A large clinical trial will test whether taking rosuvastatin daily for a year helps prevent dangerous blood clots in people with newly diagnosed or relapsed cancer who aren’t already getting anticoagulants.
-
BCOR's role in blood clot risk and liver genetics
A Johns Hopkins-led study is exploring how a human gene, BCOR, may control liver-produced clotting factors to influence venous blood clots.
-
Personalized risk-prediction for hospital-acquired blood clots in adults
A real-time risk model helps doctors identify adults in the hospital who are at higher risk of developing blood clots so they can prevent them safely.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.